Skip to content
Screener

GeneDx Holdings WGS Net debt / EBITDA

Net debt / EBITDA at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
2.6×-0.4×
Azenta logo
AzentaAZTA
-42×-10.1×
Labcorp Holdings logo
Labcorp HoldingsLH
2.9×-0.6×
Opko Health logo
Opko HealthOPK
1.2×—
CareDx logo
CareDxCDNA
-0.9×—
Revvity logo
RevvityRVTY
3.8×+0.7×

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$2.3B-27.6%
Enterprise value$2.3B-27.0%
P/S5.2×-3.6×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%—
Net margin-17.6%—
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%—
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

net debt/ebitda=0.6×

Based on the most recent quarter.

The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026. Open the filing →

Filed
May 4, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001818331-26-000041

FAQ

What is GeneDx Holdings's net debt / EBITDA?
GeneDx Holdings (WGS) reported net debt / EBITDA of 0.6× in Q4 2025.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Ask your AI about GeneDx Holdings's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude